Genomics of Drug Sensitivity in Cancer Erlotinib
Synonyms Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415
Targets EGFR
Target pathway EGFR signaling
PubCHEM ID 176870
Jsmol
Download molecule 176870
PUBCHEM IUPAC INCHI InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
Smiles O(C=1(C(OCCOC)=CC2(=C(N=CN=C2(C=1))NC3(=CC(C#C)=CC=C3))))CCOC
Cluster number 134
calculated LogS -3,527
Molecular weight 393,442
calculated LogP 3,0713
H-Acceptors 7
H-Donors 1
Ro5 violations 0
Druglikeness -5,9718
DrugScore 0,379340480582395
Mutagenic none
Tumorigenic none
Reproductive Effective none
Irritant none
Fish Toxicity High FHMT
Fish Toxicity2 1,0079
Rat Acute Toxicity 2,3958
Acute Oral Toxicity III
Caco-2 Permeability Caco2+
Caco-2 Permeability2 1,309
P-glycoprotein Substrate Substrate
P-glycoprotein Inhibitor Inhibitor
P-glycoprotein Inhibitor2 Non-inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Non-inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,6171
AMES Toxicity AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Substrate
CYP450 3A4 Inhibitor Inhibitor
CYP450 2C19 Inhibitor Inhibitor
CYP450 2C9 Inhibitor Non-inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB+
CYP Inhibitory Promiscuity High CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Non-inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -3,1592
Information useful only for research purposes.